Monica A Muñoz1, Gerald J Dal Pan2. 1. Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. monica.munoz@fda.hhs.gov. 2. Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Authors: Lisa Harinstein; Dipti Kalra; Cindy M Kortepeter; Monica A Muñoz; Eileen Wu; Gerald J Dal Pan Journal: Drug Saf Date: 2019-05 Impact factor: 5.606
Authors: James R Rogers; Ameet Sarpatwari; Rishi J Desai; Justin M Bohn; Nazleen F Khan; Aaron S Kesselheim; Michael A Fischer; Joshua J Gagne; John G Connolly Journal: Drug Saf Date: 2019-01 Impact factor: 5.606
Authors: Kevin Klein; Joep H G Scholl; Marie L De Bruin; Eugène P van Puijenbroek; Hubert G M Leufkens; Pieter Stolk Journal: Clin Pharmacol Ther Date: 2017-10-25 Impact factor: 6.875
Authors: Kathryn Marwitz; S Christopher Jones; Cindy M Kortepeter; Gerald J Dal Pan; Monica A Muñoz Journal: Drug Saf Date: 2020-05 Impact factor: 5.606